GlassScriptPhysician profile
Sergey S Ananyev
NPI 1366645459
$9,825.48
in general payments reported to CMS, 2019-2025
40 companies · $1,139 in 2025
The $1,139 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,322 · 2020: $490 · 2021: $836 · 2022: $1,002 · 2023: $879 · 2024: $1,158 · 2025: $1,139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,175.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,302.26 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Rezum Generator |
| Coloplast Corp | $2,212.24 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $1,015.95 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $816.68 | 2019-2024 | Myrbetriq |
| Antares Pharma, INC. | $668.08 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Allergan, INC. | $287.25 | 2019-2022 | |
| Abbvie INC. | $282.42 | 2022-2025 | Botox |
| Endo Pharmaceuticals INC. | $276.30 | 2019-2023 | Xiaflex |
| Urovant Sciences INC | $190.21 | 2021-2022 | |
| Medtronic, INC. | $155.89 | 2023-2024 | Interstim |
| Procept Biorobotics Corporation | $151.62 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Progenics Pharmaceuticals, INC. | $135.70 | 2021-2025 | Pylarify |
| Myriad Genetic Laboratories, INC. | $127.66 | 2022-2024 | Prolaris |
| Clarus Therapeutics INC. | $118.39 | 2021 | |
| Myovant Sciences INC. | $109.23 | 2021-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $98.17 | 2019-2024 | |
| Laborie Medical Technologies Corp. | $97.51 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System, Eclipse |
| Axonics, INC. | $89.60 | 2022-2024 | Axonics, Bulkamid |
| Endo USA, INC. | $86.03 | 2024-2025 | Xiaflex |
| Halozyme INC | $61.81 | 2023 | |
| Janssen Biotech, INC. | $50.95 | 2025 | Erleada |
| Tolmar, INC. | $46.83 | 2023-2024 | |
| Olympus America INC. | $41.12 | 2024-2025 | Itind System, Soltive |
| Urogen Pharma, INC. | $37.49 | 2021-2023 | Jelmyto |
| Immunitybio, INC. | $34.41 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $34.24 | 2019 | |
| Janssen Scientific Affairs, LLC | $32.24 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $31.28 | 2023 | Seglentis |
| Teleflex LLC | $31.20 | 2025 | Barrigel |
| Kerecis Limited | $25.14 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Calyxo, INC. | $23.09 | 2025 | Cvac Aspiration System |
| Travere Therapeutics, INC. | $21.83 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $20.23 | 2022 | |
| Verity Pharmaceuticals INC. | $19.95 | 2023 | Trelstar |
| Zyla Life Sciences, INC. | $17.71 | 2020 | |
| Baxter Healthcare | $17.02 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.23 | 2022 | |
| Merck Sharp & Dohme LLC | $14.80 | 2022 | |
| Novo Nordisk INC | $14.01 | 2024 | |
| Photocure INC | $13.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergey Ananyev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.